 |
Dittmar Böckler extends his invitation for you to join him in London at CX 2026! We have highlights across Aortic, Peripheral Arterial & CLTI, Venous & Lymphatic, Carotid & Acute Stroke, Vascular Access & Renal Interventions and Vascular Trauma. Register for cx 2026
Christopher Aylwin and Ross Davenport offer an exclusive look at the CX 2026 Vascular Trauma Programme, highlighting the range of content designed to reflect how to manage trauma in a clinical setting.
Vascular Trauma highlights include:
Andrew Holden offers an exclusive first look at the CX 2026 Peripheral Arterial Programme, highlighting the volume of new data being released and discussed.
Peripheral Arterial highlights include:
Dittmar Böckler offers an exclusive first look at the CX 2026 Aortic Programme, highlighting podium-first discussions and key clinical topics, and sharing how he looks forward to welcoming colleagues from around the world to CX 2026.
Aortic Highlights include:
Kelly Feng, winner of the Challenging Cases and Complications competition at CX 2025 discusses her experience at CX 2025. Kelly shares what inspired her to submit her entry to the Competition, reflects on her time at CX 2025, and offers advice for those considering entering the CX 2026 competition. Regsiter for cx […]
Adithi Nair, winner of ‘The Swollen Leg’ Competition infographic prize and Febe Elsayghe, winner of ‘The Swollen Leg’ Competition infomercial prize discuss their experience at CX 2025. They share what inspired them to […]
The vascular trauma programme at […]
CX 2024: An outstanding faculty will tee up timely debates to enhance vascular education
Dittmar Böckler (Heidelberg, Germany), one of co-chairs of CX 2024, rings the CX bell, and calls out the […]
[…]
Tilo Kölbel (vascular surgeon from Hamburg, Germany, and a member of the Executive Board for the Aortic Programme) makes the case for moving images that will “easily […]
Manj Gohel (Cambridge, UK) and member of the Venous Executive Board parachutes straight into the CX Venous and Lymphatics Controversies Programme to highlight the VenaSeal SPECTRUM programme, SAVVE trial and SYNCHRONOUS trial, which will all present results for the very first time to an international audience at the Charing Cross International Symposium 2024 […]
No more freestyling, reset your endovascular CLTI practice with new Level 1 evidence
Andrew Bradbury (Birmingham, UK) and the BASIL-3 team of triallists will be presenting, for the very first time, the results of this long-awaited, only fully publicly funded randomised controlled trial (RCT) at CX 2024 (23–25 April, London, UK).
In conversation with CX Chairman Professor Roger Greenhalgh, aortic expert Alexander Zimmerman (Zurich, Switzerland) discusses the upcoming Aortic course (Wednesday, 26 April), the importance of continuous education for the practicing surgeon and, a multidisciplinary approach to treating and managing the aorta.
A multidisciplinary approach to aortic aneurysm repair
Professor Zimmerman focuses on the importance of an taking interdisciplinary approach to […]
Professor Andrew Holden (Auckland, New Zealand) is really excited about the 18 podium first presentations showcasing new data at CX 2023 and uniquely, the interaction between a world-class faculty and expert audience.
| CX 2023 – PODIUM FIRST: |
In this conversation between CX chairman Roger Greenhalgh and Professor of Vascular Surgery, Maarit Venermo (Helsinki, Finland), we discuss the importance of challenging the status quo in vascular and endovascular surgery.
Professor Venermo discusses challenging the status quo in superficial femoral artery management, non-invasive methods and her thoughts on aneurysms in the carotid artery “I’ve heard some […]
Start planning your CX 2023 itinerary today! We sat down with CX Executive Board member, Tilo Kölbel (Hamburg, Germany), to discuss the upcoming presentations in the Aortic techniques & technologies sessions. Register for the CX 2023 Consensus Update today!
Tilo Kölbel’s Highlights:
“I am really looking forward to seeing everyone at CX 2023 and it is going to be a great meeting. It is a pleasure and a privilege for us to be part of it and have the opportunity to present our trial data for the first time.”
Data and discussion on revascularisation treatment […]
“It is absolutely key that we enthuse the young and that we show them what we can do in order to be interested in joining our professions.”
CX is offering more opportunities and benefits for trainees, fellows, early career surgeons and physicians than ever before. This week we sat down with Sophie Renton (London, UK), a consultant […]
Endovascular and Interventional Radiology Consultant Bella Huasen (Preston, United Kingdom) stopped by the CX studio to chat about the upcoming Charing Cross Symposium in April 2023.
Like all of us, she is looking forward to CX – to networking, debating and reaching consensus on peripheral arterial topics. We will be welcoming over 2,500 delegates, virtually and […]
This year, we aim to reach consensus on renal interventional and vascular access issues. With the help of a world-class faculty, we will be leading a one day vascular access masterclass and workshop in London, which is the largest in Europe. We spoke with CX executive board members, Nick Inston (Birmingham, UK) and Kate Steiner […]
This year we expect over 2,500 in-person and 1,000 virtual participating vascular specialists to join us. In previous years we have hosted over 6,000 registrants virtually from over 120 countries due to the COVID-19 pandemic and are very excited to be back in London 25-27 April 2023. To make CX as accessible as possible, registrants will also have […]
CX 2023 is seeking to reach venous and lymphatic consensus on topics related to the superficial, deep and pelvic veins as well as venous ulcers and lymphatics. Reaching consensus this year will round out our three-year cycle of controversies, challenges and consensus. Topics will be addressed by the world-class CX faculty alongside […]
Sophie Renton (London, UK) moderates a session with Michel Makaroun (Pittsburgh, USA) and Armando Mansilha (Porto, Portugal) where the trio discuss some of the challenges relating to recruitment within the field of vascular surgery.
Makaroun explains that there are two main recruitment pathways into vascular surgery in the USA but notes […]
Kevin Mani (Uppsala, Sweden) chats to BLearning about the upcoming Aortic Workshop at CX 2020 (Charing Cross Symposium; 21–24 April, London, UK), noting how the sessions will give attendees access to experts, the latest technologies and provide a platform for hands-on experience with new devices and imaging technology.
Workshop participants can take this […]
Roger Greenhalgh (London, UK) speaks to former president of the SVS (2018–2019) Michel Makaroun (Pittsburgh, USA) about the CX Symposium which Makaroun says “always has a special flavour” and is “a special meeting”. Makaroun also touches on some of the similarities and differences between CX and the SVS meeting in […]
Roger Greenhalgh (London, UK) and W L Gore’s Michael Koenke (Flagstaff, USA), take a look back at the history of the Charing Cross Symposium (CX), which began in 1978.
Koenke says that CX is a “special meeting for us”, adding that it is an “opportunity for us to connect with our […]
Roger Greenhalgh (London, UK) chats with Enrico Ascher (New York, USA) about some of the highlights of the CX Symposium, how it differs to the VEITH symposium in the USA and also how the two complement each other.
Ascher says he is always “totally amazed by the scientific level” of CX, […]
Alberto Muñoz (Bogota, Colombia) talks to BLearning at CX 2019 (Charing Cross Symposium; 15–18 April, London, UK) about how the meeting provides a “great opportunity” to update attendees on the latest in vascular and endovascular surgery.
Muñoz goes on to highlight the international flavour of Charing Cross and notes the importance of the […]
Giovanni Torsello (Münster, Germany) and Mauro Gargiulo (Bologna, Italy) discuss the “very high” morbidity and mortality caused by open surgery when treating complex aortic aneurysms. This is […]
The 2019 Charing Cross Symposium (CX; 15–18 April, London, UK) featured an in-depth highlight session on the paclitaxel controversy. […]
Paul Hayes (Cambridge, UK), Frank Arko (Charlotte, USA) and Fabio Verzini (Turin, Italy) discuss the Valiant Navion™ (Medtronic) live thoracic endovascular aortic repair (TEVAR) case at Charing Cross 2019, which demonstrated the use of the new CoveredSeal proximal configuration.
Hayes talks about the accuracy of the device’s deployment around the thoracic […]
Matteo Tozzi (Varese, Italy) discusses new data from the APERTO AVF study, the first randomised trial in China to compare the safety and efficacy of the APERTO drug-coated balloon (DCB; Cardionovum) with a high-pressure balloon. The trial results for the treatment of failing haemodialysis arteriovenous shunts were presented by Qizhuang […]
Dittmar Boeckler (Heidelberg, Germany) tells CX Live that treating patients with thoracic endovascular aortic repair (TEVAR) outside the instructions for use (IFU) has a dramatic effect on patient outcomes after the procedure. “We observed a significant increase in mortality […] an increased reintervention rate and four times higher endoleak rate,” […]
Michael Edmonds (London, UK), Thomas Serena (Warren, USA), Keith Harding (Cardiff, UK), and Williams Ennis (Oak Lawn, USA) talk at CX Live about the first ever iWounds workshop, the importance of wound management and what they hope to achieve.
Edmonds discusses why “too many legs are being lost” and Serena talks […]
Following the latest information presented at the Charing Cross International Symposium related to the meta-analysis of paclitaxel-coated devices (Katsanos et al, JAHA), hear from a multi-specialty panel of global experts who are discussing their current practice and the way they […]
Jade Hiramoto (San Francisco, USA) tells CX Live about why she believes “everyone should consider normalising glucose levels after long, complex endovascular aortic procedures—and maybe even after open thoracoabdominal aortic procedures.”
Hiramoto is presenting new research on this topic at the Charing Cross session on Spinal Cord Ischaemia in the Upper […]
Jonathan Beard, (Sheffield, UK), discusses the current medicolegal issues in the field and explains how vascular surgeons can become “the fall-guy for the inadequacies of other clinicians”. Beard touches on how the threshold for informed consent has changed “dramatically” in recent years which has led to “the death of […]
At the Charing Cross International Symposium, Gary Ansel (Columbus, Ohio) moderates a global panel that includes Thomas Albrecht (Berlin, Germany), Peter Schneider (San Francisco, USA) and Eric Secemsky (Boston, USA). The panel outlines the value of paclitaxel devices in the treatment of peripheral arterial disease patients; examines new evidence on […]
There were several calls at the CX 2019 Highlight Session Paclitaxel: The last word on the need for a meta-analysis of individual patient-level data going forward and greater transparency and sharing of the available randomised controlled trial data of paclitaxel-coated devices.
Cook Medical has just announced the release of de-identifiable […]
Elena Ladich (Hollywood, USA) and Roger Greenhalgh (London, UK) discuss the current uncertainty surrounding the use of paclitaxel devices and the need for individual patient-level data analyses going forward to better understand the mortality signal raised by the Katsanos et al meta-analysis.
Ladich believes that “we need to take a step […]
In the Acute Stroke Challenges session on Monday, Nick Hopkins talks to CX Live about the “significant increase” of incidents of stroke following cardiac surgery which is “much more common than previously thought”.
Ross Naylor and Peter Schneider debated the impact of new technologies and innovations making carotid artery stenting as […]
CX Executive Board Members Gunnar Tepe and Thomas Zeller introduce the CX Special Session which aims to give the last word on paclitaxel and work with the vascular community to find the way forward.
Watch the video below, and see the final CX 2019 programme here.
[…]
The publication of the draft aortic guidelines by the National Institute for Health and Care Excellence (NICE) in May 2018 raised quite a stir.
However, the story is not over. In a CX Special Session, new analysis will show what we now know about long-term EVAR outcomes, and the vascular community’s concerns over the […]
CX is Europe’s largest and longest-running vascular symposium and delivers vascular EDUCATION as it should be
CX raises CONTROVERSIES, CHALLENGES the evidence to reach CONSENSUS in a three yearly cycle after discussion involving a world-class faculty and expert audience.
CX uses both live cases and edited cases from leading aortic, peripheral and venous centres to illustrate […]
Since the publication of Katsanos et al’s meta-analysis in the Journal of the American Heart Association (JAHA), the science and support for paclitaxel-releasing devices in the legs is an unfolding story.
A CX 2019 Highlight session will feature two hours of independent review of the data and in-depth debate and discussion.
CX […]
Nicholas Inston, member of the CX Vascular Access Executive Board, gives the highlights for this year’s CX Vascular Access Masterclass which will focus on the maintenance and not just the formation of vascular access.
Stephen Black, member of the CX Venous Executive Board, describes the wonderful opportunity that the Charing Cross Venous Challenges Programme offers as it brings together key developments in the science, learning experience in the Venous Village and input from the international faculty who share their vision.
Manj Gohel, member of the CX Venous Executive Board, previews some of the fantastic educational activity that is being planned for CX 2019.
From new outcomes of paclitaxel-coated devices to DCB use below the knee, the CX Peripheral Executive Board looks ahead to CX 2019 and raises some of the key questions that will be addressed in the programme.
In this interview, Meryl Davis, chair of the CX Abstract Board, talks about the benefits of presenting research at the CX Symposium and the importance of CX as a “global village”.
The CX Abstract Board is calling for senior and trainee doctors in the vascular and endovascular field to submit their […]
Alun Davies, EVRA chief investigator
Imperial College, London, United Kingdom
This year, CX celebrates 40 Years of Looking Forward. In this video, members of the CX Programme Organising Board and the CX Faculty explain why CX is not only unique but also provides vascular education “as it should be”! Register now for CX 2018!
[…]
Fabrizio Fanelli (Florence, Italy), CX Faculty, says that a key point about CX is that it – unlike other meetings – provides opportunities for discussion. He notes that the “active discussion” at the podium is “very important” for what you learn at the meeting. Register for CX 2018!
[…]
CX Faculty member Barry Katzen (Miami, United States) discusses how attending CX has affected his clinical practice and how he always is “universally losing” debates at CX! Register for CX 2018!
CX programme organising board member Alun Davies (Imperial College, London, United Kingdom) reviews how CX has changed in the last 24 years that he has been attending the symposium, his most memorable moments, and the one word he would use to describe the meeting. Register for CX 2018!
[…]
“One of the great things” about CX, according to CX Faculty member Kathleen Gibson (Bellevue, United States), is that it provides a “global perspective”. She says she “learns more and more” every time she attends. Register for CX 2018!
Rodney White (Torrance, United States), CX Faculty, says that CX has been a “very good forum” for not only new technologies but also how we adapt them to current practice. He notes that CX chairman Roger Greenhalgh has always been at the forefront of the latest developments. Register for CX 2018!
Lowell Kabnick (New York, United States), who is a CX Faculty member, describes how the CX Venous Workshop has gone from being a small intimate session to one that, while still intimate, is “really large and all inclusive”. He adds that he believes that it is the best he has seen.
[…]
Meryl Davis, member of the CX Abstracts Board, talks about the invaluable opportunity for senior and trainee vascular and endovascular clinicians to present at the CX Abstract sessions.
The CX Venous Consensus Update—Plenary Programme took place on the first day of CX 2017 (Tuesday, 25 April). Stephen Black, member of the CX Programme Organising Board, summarises the take-home messages of this session.
The CX 2017 Peripheral Arterial Consensus Update Programme will focus on PATHWAYS OF CARE – whether to intervene, when and at what threshold, method and follow-up.
“Over three days (25–27 April) there will be a comprehensive coverage of the most important aspects of peripheral arterial intervention as well as some important new trial evidence being presented […]
Interventions in the aorta and manipulations in the aortic arch have become a “potential source of embolisation to the brain,” notes Roger Greenhalgh, Chairman of the CX Programme Organising Board. The Acute Stroke Consensus Plenary Programme will address the scope of this problem and PATHWAYS OF CARE to treat acute stroke from a multidisciplinary perspective including: […]
The CX 2017 Venous Consensus Update Programme will focus on PATHWAYS OF CARE – whether to intervene, when and at what threshold, method and follow-up, providing delegates with discussions on diagnosis and treatment options for the whole spectrum of venous disease.
Roger Greenhalgh (Chairman, CX Programme Organising Board) discusses with Stephen Black (member, CX Programme Organising […]
Roger Greenhalgh, Chairman of the CX Programme Organising Board, discusses the highlights of the Aortic Edited Cases session at CX 2017.
Complementing the Aortic Plenary Programme, experts in aortic surgery will discuss “tips and tricks” in thoracic, juxtarenal and abdominal aortic reconstructions and also ascending aorta and arch intervention, showing specific techniques and technologies with edited […]
Roger Greenhalgh, Chairman of the CX Programme Organising Board, discusses the highlights of the Thoracic Aortic Consensus Plenary Programme at CX 2017.
Key topics to be discussed include:
Roger Greenhalgh, Chairman of the CX Programme Organising Board, discusses the highlights of the Abdominal Aortic Consensus Plenary Programme at CX 2017.
Key topics include:
What are the special features of the CX Symposium? Matt Thompson, Co-chairman of the CX Programme Organising Board, highlights “a plethora of educational opportunities” including presentation of new evidence, key messages voiced by opinion leaders, debate and case-based discussion amongst others.
What makes CX so special for you? Tweet your […]
What are the special features of the CX Symposium? CX Programme Board member Thomas Zeller (Professor of Angiology at Albert-Ludwigs University of Freiburg and Head of Department of Angiology at Universitäts – Herzzentrum Freiburg, Bad Krozingen, Germany) considers “the Discussion Culture” and exchange between the CX Faculty and the audience unique.
CX Faculty members discussed “Life after EVAR 1” at LINC (24‒27 January 2017, Leipzig, Germany). Frans Moll, Co-chairman CX Programme Organising Board, summarises the take-home messages from the session.
Continue the discussion on “Life after EVAR 1” at CX 2017 ( 25‒28 April, Olympia Grand, London, UK). Register here […]
What are the special features of the CX Symposium? CX Programme Organising Board member Andrew Holden (Associate Professor of Radiology at Auckland University School of Medicine and Director of Interventional Services at Auckland City Hospital, Auckland, New Zealand) highlights the discussion, debate and “a drive to get consensus”.
Pasha Normahani (Imperial Vascular Unit, Imperial Academic Health Science Centre, London, UK) has been an attendee at the Charing Cross (CX) Symposium for over seven years. In 2016, he presented for the first time at the CX Abstract sessions and was awarded with a Certificate of Merit for his research in peripheral arterial disease. In […]
Ian Loftus, Co-chairman CX Abstract Board, reviews the highlights of this year’s CX Abstract Presentations session. He emphasises the quality of the work submitted and how relevant it is for young and senior clinicians to present their research at the Charing Cross Symposium.
“The Peripheral Arterial Programme at the Charing Cross Symposium in 2016 is really exciting; it combines the hot topics in the field with evidence, opinion and discussion,” says Andrew Holden (Auckland, New Zealand), member of the CX Programme Organising Board. He overviews key areas to be discussed on Tuesday 26 April including the management of […]
In 2016, the Charing Cross Venous Programme will run on the four days of the Symposium (26–29 April) with the Main Programme for the first time on day 1, followed by the CX Venous Workshop on days 2 and 3, and the CX Venous Abstract Presentations on day 4. Ian Franklin (London, UK), member of […]
Stephen Black (London, UK), member of the CX Programme Organising Board, discusses the highlights of this year’s Deep Venous section of the CX Venous Challenges Day.
“There has never been a more exciting expectation of what we have for this year in the aortic area at CX,” says Roger Greenhalgh, chairman of the CX Programme Organising Board. Results from the Individual Patient Data meta-analysis of the four randomised controlled trials on endovascular aneurysm repair against open repair (EVAR 1, DREAM, OVER […]
Ian Franklin, a member of the CX Programme Organising Board and director of the CX Venous Workshop, speaks about new technologies for the treatment of varicose veins and about how deep venous interventions have been incorporated to the CX Venous Workshop.
Janet Powell, Imperial College, London, UK, is interviewed about the 12-month results of the IMPROVE trial, presented for the first time at CX 2015. The study compares open repair and an endovascular strategy for ruptured abdominal aortic aneurysms.
Colin Bicknell, London, UK, interviews Michael Dake, Stanford, USA, discussing the use of, and early results for, the new GORE TAG Thoracic Branch Endoprosthesis device.
Reconstruction of the ascending aorta – Interview with Rodney White
Interview for CX 2015
Richard Gibbs, member of the CX Abstract Board, speaks about the 2015 CX Abstract Sessions, their importance for this year’s Charing Cross Symposium, and how these sessions can help spotting new talent.